| Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy I Pedroza-Pacheco, A Madrigal, A Saudemont Cellular & molecular immunology 10 (3), 222-229, 2013 | 191 | 2013 |
| Cytoskeletal actin dynamics shape a ramifying actin network underpinning immunological synapse formation M Fritzsche, RA Fernandes, VT Chang, H Colin-York, MP Clausen, ... Science advances 3 (6), e1603032, 2017 | 168 | 2017 |
| Immune perturbations in HIV–1-infected individuals who make broadly reactive neutralizing antibodies MA Moody*, I Pedroza-Pacheco*, NA Vandergrift, C Chui, KE Lloyd, ... Science immunology 1 (1), aag0851, 2016 | 115 | 2016 |
| Asymptomatic primary infection with Epstein-Barr virus: observations on young adult cases RJ Abbott, A Pachnio, I Pedroza-Pacheco, AM Leese, J Begum, HM Long, ... Journal of Virology 91 (21), e00382-17, 2017 | 88 | 2017 |
| RAB11FIP5 expression and altered natural killer cell function is associated with induction of HIV broadly neutralizing antibody responses BH T Bradley*, D Peppa* , I Pedroza-Pacheco*, D Li*, D Cain , R Henao, V ... Cell 175, 1-13, 2018 | 77* | 2018 |
| Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth KM Roskin, KJL Jackson, JY Lee, RA Hoh, SA Joshi, KK Hwang, ... Nature immunology 21 (2), 199-209, 2020 | 70 | 2020 |
| Adaptive reconfiguration of Natural Killer cells in HIV-1 infection D Peppa, I Pedroza-Pacheco, P Pellegrino, I Williams, MK Maini, ... Frontiers in Immunology 9, 474, 2018 | 66 | 2018 |
| Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors CM Nielsen, A Ogbe, I Pedroza-Pacheco, SE Doeleman, Y Chen, SE Silk, ... Cell Reports Medicine 2 (3), 2021 | 41 | 2021 |
| Pharmacological activation of the circadian component REV-ERB inhibits HIV-1 replication H Borrmann, R Davies, M Dickinson, I Pedroza-Pacheco, M Schilling, ... Scientific reports 10 (1), 13271, 2020 | 40 | 2020 |
| Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly … M Luevano, A Domogala, M Blundell, N Jackson, I Pedroza-Pacheco, ... PloS One 9 (1), e87086, 2014 | 39 | 2014 |
| IL-2 regulates expression of C-MAF in human CD4 T cells A Rani, B Afzali, A Kelly, L Tewolde-Berhan, M Hackett, AS Kanhere, ... The Journal of Immunology 187 (7), 3721-3729, 2011 | 39 | 2011 |
| Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity L Chauveau, A Bridgeman, TK Tan, R Beveridge, JN Frost, P Rijal, ... EMBO reports 22 (8), e52447, 2021 | 27 | 2021 |
| Hypoxic microenvironment shapes HIV-1 replication and latency X Zhuang, I Pedroza-Pacheco, I Nawroth, AE Kliszczak, A Magri, W Paes, ... Communications Biology 3 (1), 376, 2020 | 26 | 2020 |
| Regulatory T cells inhibit CD34+ cell differentiation into NK cells by blocking their proliferation I Pedroza-Pacheco, D Shah, A Domogala, M Luevano, M Blundell, ... Scientific Reports 6, 22097, 2016 | 14 | 2016 |
| Differential effects of mycophenolate mofetil and cyclosporine A on peripheral blood and cord blood natural killer cells activated with interleukin-2 S Derniame, J Perazzo, F Lee, A Domogala, M Escobedo-Cousin, ... Cytotherapy 16 (10), 1409-1418, 2014 | 12 | 2014 |
| Subordinate effect of-21M HLA-b dimorphism on NK cell repertoire diversity and function in HIV-1 infected individuals of African origin EM Cubero, A Ogbe, I Pedroza-Pacheco, MS Cohen, BF Haynes, ... Frontiers in Immunology 11, 156, 2020 | 7 | 2020 |
| Immune signature atlas of vaccines: learning from the good responders I Pedroza-Pacheco, AJ McMichael Nature immunology 23 (12), 1654-1656, 2022 | 5 | 2022 |
| Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies. Sci Immunol. 2016; 1 (1): aag0851 MA Moody, I Pedroza-Pacheco, NA Vandergrift, C Chui, KE Lloyd, ... HIV-1-infected individuals who make HIV-1 envelope (Env)-reactive, broadly …, 0 | 4 | |
| Harnessing CXCL13 in ovarian cancer E Brenna, I Pedroza-Pacheco Nature Reviews Immunology 22 (3), 145-145, 2022 | 3 | 2022 |
| Targeting autoantibodies in COVID-19 I Pedroza-Pacheco, P Borrow Nature Reviews Immunology 21 (3), 134-134, 2021 | 3 | 2021 |
Nathan A. VandergriftSenior Research Statistician, RTI International在 rti.org 的电子邮件经过验证
